Percutaneous valvular intervention is a novel approach in the treatment of valvular diseases. The common percutaneous valvular interventions are mitral balloon valvuloplasty (PTMC), percutaneous mitral valve repair, aortic valvuloplasty, percutaneous aortic valve replacement, percutaneous and transapical aortic valve replacement, pulmonary valvuloplasty, percutaneous pulmonary valve replacement, percutaneous tricuspid valvuloplasty, percutaneous tricuspid valve replacement. 1 The era of percutaneous therapy for valvular heart disease began with balloon valvuloplasty for pulmonic stenosis in the early 1980s. Following the demonstration of the success of this procedure, larger and additional balloon techniques were developed to treat mitral and aortic stenosis as well 2 . Percutaneous mitral valvuloplasty (PTMC) opened the window of interventional treatment of valvular heart disease when it was first performed in 1982 in patients with rheumatic mitral stenosis. 12 . Pulmonary valve replacement was started in 2000. The major drawback in pulmonary valve replacement is limitation in bovine jugular venous valve. It rarely exceeds 18 to 22 mm in diameter. Two strategies being promising in pulmonary valve replacement. These are minimally invasive surgery to downsize the outflow tract with two external rings and then va lve implanted by percutaneous approach .A self expand ing stent frame anchored in the enlarged pulmonary trunk and a centre designed to house the smaller jugular valve 13 . This is an exciting time in an arena that promises to be a new paradigm in the treatment of patients with mitral regurgitation. The timeline and pathway by which these devices are safely and effectively integrated into the current treatment of patients with mitral regurgitation is as yet undefined. Nonsurgical treatments for mitral regurgitation have focused on three main approaches to percutaneous mitral repair: indirect annuloplasty via the coronary sinus, direct transatrial, ventricular, or pericardial annuloplasty and edge-to-edge leaflet repair 12 . Every day, there is new progress in the evolving innovative development in the percutaneous approaches of the management of valvular diseases. With the innovations of percutaneous valve replacement new rays of hope are shed on the group of the patients who denied surgery for high risks. Standing at this point when we look back, we see PTMC has gained its foothold. In developing countries it renders unmeasurable services to innumerable patients. We can foresee that percutaneous mitral valve repair will be a complementary to surgical mitral va lve repair in the near future. This is the field where lessons from the past suggest that a close collaboration between interventionists and surgeons is of utmost importance. Endeavor of percutaneous transapical aortic valve replacement teaches us that apparently competitive procedures have had the virtue of approximating the cardiological and surgical groups, as the collaboration of a surgeon in a typical cardiological field and of a cardiologist in a typical surgeon's field is judged essential by almost everybody involved. 
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